Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1952 2
1957 1
1959 1
1960 1
1962 1
1963 1
1964 4
1965 2
1966 1
1967 3
1968 1
1969 6
1970 2
1971 4
1972 3
1973 4
1974 8
1975 5
1976 1
1977 2
1978 2
1979 7
1980 3
1981 5
1982 3
1983 4
1984 4
1985 5
1986 2
1987 4
1988 7
1989 3
1990 3
1992 6
1993 2
1994 2
1996 1
2000 3
2003 1
2004 1
2005 4
2006 4
2007 10
2008 10
2009 8
2010 12
2011 11
2012 18
2013 27
2014 23
2015 21
2016 14
2017 18
2018 21
2019 18
2020 20
2021 24
2022 30
2023 15
2024 21
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

414 results

Results by year

Filters applied: . Clear all
Page 1
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, Gümüş M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B; LITESPARK-005 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Aug 22;391(8):710-721. doi: 10.1056/NEJMoa2313906. N Engl J Med. 2024. PMID: 39167807 Clinical Trial.
Decompression alone or with fusion for degenerative lumbar spondylolisthesis (Nordsten-DS): five year follow-up of a randomised, multicentre, non-inferiority trial.
Kgomotso EL, Hellum C, Fagerland MW, Solberg T, Brox JI, Storheim K, Hermansen E, Franssen E, Weber C, Brisby H, Algaard KRH, Furunes H, Banitalebi H, Ljøstad I, Indrekvam K, Austevoll IM; Nordsten collaborators. Kgomotso EL, et al. BMJ. 2024 Aug 7;386:e079771. doi: 10.1136/bmj-2024-079771. BMJ. 2024. PMID: 39111800 Free PMC article. Clinical Trial.
A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study.
Ning J, Spielvogel CP, Haberl D, Trachtova K, Stoiber S, Rasul S, Bystry V, Wasinger G, Baltzer P, Gurnhofer E, Timelthaler G, Schlederer M, Papp L, Schachner H, Helbich T, Hartenbach M, Grubmüller B, Shariat SF, Hacker M, Haug A, Kenner L. Ning J, et al. Among authors: haug a. Theranostics. 2024 Aug 1;14(12):4570-4581. doi: 10.7150/thno.96921. eCollection 2024. Theranostics. 2024. PMID: 39239512 Free PMC article.
Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis.
Häggström I, Leithner D, Alvén J, Campanella G, Abusamra M, Zhang H, Chhabra S, Beer L, Haug A, Salles G, Raderer M, Staber PB, Becker A, Hricak H, Fuchs TJ, Schöder H, Mayerhoefer ME. Häggström I, et al. Among authors: haug a. Lancet Digit Health. 2024 Feb;6(2):e114-e125. doi: 10.1016/S2589-7500(23)00203-0. Epub 2023 Dec 21. Lancet Digit Health. 2024. PMID: 38135556 Free PMC article.
A national precision cancer medicine implementation initiative for Norway.
Taskén K, Russnes HEG, Aas E, Bjørge L, Blix ES; CONNECT Public–Private Partnership Consortium; Enerly E, Fagereng GL, Flobak Å, Gilje B, Gjertsen BT, Guren TK, Heix J, Hovig E, Hovland R; InPreD-Norway and National Molecular Tumor Board Consortium; IMPRESS-Norway Consortium; Lønning PE, Meza-Zepeda LA, Mæhle PM, Nilsen HL, Thoresen SØ, Widerberg K, Smeland S, Helland Å. Taskén K, et al. Nat Med. 2022 May;28(5):885-887. doi: 10.1038/s41591-022-01777-4. Nat Med. 2022. PMID: 35513529 No abstract available.
Tongue-tie in neonates.
Haug AC, Markestad T, Tjora E, Moster D. Haug AC, et al. Tidsskr Nor Laegeforen. 2021 Aug 12;141. doi: 10.4045/tidsskr.21.0515. Print 2021 Sep 28. Tidsskr Nor Laegeforen. 2021. PMID: 34597009 Free article. English, Norwegian. No abstract available.
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial.
Midgard H, Malme KB, Pihl CM, Berg-Pedersen RM, Tanum L, Klundby I, Haug A, Tveter I, Bjørnestad R, Olsen IC, Finbråten AK, Dalgard O. Midgard H, et al. Among authors: haug a. Clin Infect Dis. 2024 Mar 20;78(3):582-590. doi: 10.1093/cid/ciad711. Clin Infect Dis. 2024. PMID: 37992203 Free PMC article. Clinical Trial.
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Werner R, Haug A, Buske C, Heidegger S, Illert AL, Bassermann F, Herhaus P, Buck A, Duell J, Topp MS, Kraus S, Einsele H, Lapa C, Raderer M, Lenz G, Habringer S, von Tresckow B, Keller U. Werner R, et al. Among authors: haug a. Nuklearmedizin. 2024 Apr;63(2):57-61. doi: 10.1055/a-2194-9965. Epub 2024 Jan 8. Nuklearmedizin. 2024. PMID: 38190998 Free PMC article.
Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties.
Volmar MNM, Cheng J, Alenezi H, Richter S, Haug A, Hassan Z, Goldberg M, Li Y, Hou M, Herold-Mende C, Maire CL, Lamszus K, Flüh C, Held-Feindt J, Gargiulo G, Topping GJ, Schilling F, Saur D, Schneider G, Synowitz M, Schick JA, Kälin RE, Glass R. Volmar MNM, et al. Among authors: haug a. Neuro Oncol. 2021 Nov 2;23(11):1898-1910. doi: 10.1093/neuonc/noab095. Neuro Oncol. 2021. PMID: 33864076 Free PMC article.
414 results